| Revenue Growth | Q3 revenue up 8.9%; 5.7% discharge growth; 4% net revenue per discharge. |
|---|---|
| Mgmt Confidence | High confidence; raising 2026 guidance for revenue, EBITDA, and adjusted EPS. |
| Demand Visibility | Strong demand; 58 hospitals at >90% occupancy; 20% VA segment growth. |
| Order Book | Pipeline of 15 announced hospitals with 654 beds beyond 2026. |
| Margin Trends | Adjusted EBITDA margin improved; premium labor spend declined $3.9M year-over-year. |
| Op. Leverage | SWB per FTE up 3.8%; contract labor at record low 0.9%. |
| Pricing Power | Net revenue per discharge up 4% driven by higher patient acuity. |
| Vol vs Price | Growth driven by 5.7% volume increase and 4% pricing/acuity improvement. |
| Segment Growth | Stroke patients up 5.1%; Neuro up 9.3%; Major Trauma up 10.3%. |
| New Clients | VA growth of 21% in Q3; 15 prioritized markets in North Carolina. |
| Capex & Debt | Net leverage 1.8x; $203.7M share repurchases year-to-date; $100M senior notes issued. |
| Regulatory | RCD expansion to 75 hospitals; Florida Medicaid supplemental payment reversal $9.2M. |
| Commentary | Hub and spoke strategy utilizing new small-format hospitals to address capacity. |
| New Launches | New hospitals in North Town, Bangor, San Antonio; first small-format hospitals planned. |
Growth
Revenue grew 8.9% to $6.45-$6.5B guided range; adjusted EBITDA increased 15.5% to $346.6M.
Outlook
Opening 6-10 hospitals annually; 150-200 beds adding in 2027; 15-hospital pipeline with 654 beds.
Risks
System conversion caused bad debt spike to 2.7%; RCD expansion creates administrative uncertainty for 75 hospitals.
The company's earnings call, NYSE: EHC, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Encompass Health Corp: key numbers
- Share price
- $142.11Close, Nov 16
- Market cap
- $13.9B
- Shares outstanding
- 98.12MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-HospitalsSIC 8060
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Encompass Health Corp
All →Encompass Health Business Update
Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.
Encompass Health Q3 2026 Results: Net Income $150M, Up 18.5% YoY
Encompass Health reported net operating revenues of $1,609.5 million for the third quarter of 2026, a 9% increase over the prior year. Net income attributable to the company rose to $149.9 million, driven by strong performance in continuing operations despite increased operating expenses and share repurchases totaling $204.2 million for the nine-month period.
- Key figure
- Net income $150M · +18.5% YoY
Encompass Health Financial Results
Encompass Health reported Q3 2026 net operating revenue of $1.61 billion, an 8.9% increase year-over-year, driven by a 5.7% growth in discharges. The company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS following strong performance and the opening of four new hospitals year-to-date.
- Term
- Q3 2026
“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%. During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”
Mark Tarr, President and Chief Executive Officer